Study of AT-752 in Healthy Subjects in a Dengue Human Challenge Model

Stopped early · Phase 1 · Has a placebo group

Conditions studied: Dengue

In brief

This study will assess the safety and antiviral activity of AT-752 in healthy subjects in a Dengue Human Challenge Model

Key facts

Study ID

NCT05366439

Run by

Atea Pharmaceuticals, Inc.

People needed

5

Starts

2022-04-22

Expected to finish

2023-03-16

Last updated by the study team

2023-04-21

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Must agree to use protocol-specified methods of contraception
• Negative pregnancy test
• Willing to comply with the study requirements and to provide written informed consent

You may not qualify if…

• Pregnant or breastfeeding
• Abuse of drugs
• Other clinically significant medical conditions

Where it is running

• Atea Study Site — Syracuse, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.